Comparative study on Lewis lung tumor lines with 'low' and 'high' metastatic capacity. II. Cytochemical and biochemical evidence for differences in glycosaminoglycans.
The enhanced metastatic capacity of an in vivo selected Lewis lung tumor line (LLT-HH) was correlated with changes in cell-associated glycosaminoglycans (GAG) using ultrastructural cytochemistry, flow cytometry and biochemistry. The increase in highly sulphated GAG content on the cell membrane of LLT-HH cells compared to the parent LLT cells was demonstrated cytochemically. Using in vitro [3H]glucosamine labelling of GAG components it was shown that the LLT-HH cells were characterized by a high production of heparan sulphate while the parent LLT line had a high hyaluronic acid-chondroitin sulphate production. The high metastatic phenotype is accompanied by an altered production of cell-associated GAGs.
D000818:Animals; D002277:Carcinoma / Q000473:pathology / Q000503:physiopathology*; D002448:Cell Adhesion; D002455:Cell Division; D002478:Cells, Cultured; D002809:Chondroitin Sulfates / Q000378:metabolism; D005434:Flow Cytometry; D006025:Glycosaminoglycans / Q000502:physiology*; D006497:Heparan Sulfate / Q000378:metabolism; D006651:Histocytochemistry; D006820:Hyaluronic Acid / Q000378:metabolism; D051379:Mice; D009362:Neoplasm Metastasis
D002809:Chondroitin Sulfates; D006025:Glycosaminoglycans; D006497:Heparan Sulfate; D006820:Hyaluronic Acid